First quarter of 2022: ASA continues to grow

08 April 2022 - Corporate -

The figures leave no room for doubt: for ASA, the first quarter of 2022, compared to the same period of 2021, continues to show growth, both in terms of turnover and in terms of the devices produced.

This is the result of a well thought-out commercial strategy aimed at consolidating existing businesses while developing high-potential markets.

“We have been achieving these objectives thanks to a solid policy of working alongside our long-term partners, to whom we offer continuous support in planning activities and new functional products and technologies to gain a leading role in the market. Instead, in countries we are approaching for the first time, we have been focusing on supporting daily information and training activities to promote the dissemination of our technologies and therapies”.

And during the first three months of the year, these therapies confirmed their growth and worldwide distribution.
The complex global socio-economic situation, together with the post-pandemic implications, has had a tangible impact on the company, but does not limit development projects.

“Pressure on prices, difficult-to-manage procurement schedules for components and packaging and significant increases in energy and transport costs are some of the critical issues we have to deal with on a daily basis. Unfortunately, we do not expect the situation to become stable any time soon, so we remain flexible and responsive to individual markets with very different commercial and training needs, but all equally relevant. Our distributors are aware of the situation and they are not quitting; they know that business is not only about the product: relationships and common visions are essential to win”,

concludes Federico Castellani - ASA Sales Manager.

You might also be interested in ...

See all articles

Asian Star in ASA HQ
News - 25/07/2022
After two years of exclusively virtual communication with our partners in the Far East, visits to Italy by our international partners and collaborators have resumed.
Gulbis at Vicenza ATP Challenger Tour
News - 30/05/2022
As a Vicenza-based company active in the production of laser therapies also intended for rehabilitation, we could not miss this appointment. Tennis players often have to deal with musculoskeletal...
ASA 2021 consuntivo
News - 25/01/2022
Record-breaking results for ASA’s 2021, heading toward a 2022 that holds new challenges.
Training HIRO TT - Athens
News - 28/11/2022
To provide indications useful for the best use of HIRO TT to physiotherapy and rehabilitation specialists partners of ASA and, in parallel, to present the strong points of the device to professionals...
Medica 2022 - ASA staff
News - 24/11/2022
For the 2022 edition of Medica, ASA steps on the throttle by adding to the institutional stand a satellite exhibition space in pavilion 4, focused on physiotherapy.
Trattamento Hilterapia contro la fascite plantare
Blog - 23/11/2022
Hilterapia® allows a rapid solution of the painful symptoms linked to plantar fasciitis, especially when combined with radial shock waves.